Pages that link to "Q36867815"
Jump to navigation
Jump to search
The following pages link to The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes (Q36867815):
Displaying 33 items.
- A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription (Q22010943) (← links)
- Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage (Q24646800) (← links)
- Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges (Q26796314) (← links)
- Database of T cell-defined human tumor antigens: the 2013 update (Q27022422) (← links)
- Expression of tumor-rejection antigens in gynecologic cancers (Q28138549) (← links)
- Cytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptide (Q28146219) (← links)
- Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients (Q28361963) (← links)
- A processed pseudogene codes for a new antigen recognized by a CD8( ) T cell clone on melanoma. (Q30865419) (← links)
- Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402 (Q34173622) (← links)
- An antigenic peptide produced by reverse splicing and double asparagine deamidation (Q34192290) (← links)
- Alternative Translational Reading Frames as a Novel Source of Epitopes for an Expanded CD8 T-Cell Repertoire: Use of a Retroviral System to Assess the Translational Requirements for CTL Recognition and Lysis (Q34347168) (← links)
- Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway (Q34374454) (← links)
- Novel biochemistry: post-translational protein splicing and other lessons from the school of antigen processing (Q34401747) (← links)
- Development of effective immunotherapy for the treatment of patients with cancer (Q34647354) (← links)
- Non-conventional sources of peptides presented by MHC class I (Q34768462) (← links)
- Developing recombinant and synthetic vaccines for the treatment of melanoma. (Q38636196) (← links)
- Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation (Q36121851) (← links)
- Tumor Antigens Discovery: Perspectives for Cancer Therapy (Q36438078) (← links)
- Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma (Q36696205) (← links)
- Enhancing Cancer Immunotherapy by Intracellular Delivery of Cell-Penetrating Peptides and Stimulation of Pattern-Recognition Receptor Signaling (Q37139813) (← links)
- B16 as a mouse model for human melanoma (Q37390912) (← links)
- A novel splice variant of Pmel17 expressed by human melanocytes and melanoma cells lacking some of the internal repeats. (Q37476322) (← links)
- Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes (Q37851050) (← links)
- I've got algorithm: predicting tumor and autoimmune peptide targets for CD8 T cells (Q38731152) (← links)
- Immune targets and neoantigens for cancer immunotherapy and precision medicine (Q39057617) (← links)
- Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands. (Q40264818) (← links)
- Human tumor antigens recognized by T-cells (Q41687574) (← links)
- An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes (Q42058413) (← links)
- Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions (Q42835548) (← links)
- Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy (Q47797670) (← links)
- Developing effective tumor vaccines: basis, challenges and perspectives (Q87335130) (← links)
- Alternative tumour-specific antigens (Q91666603) (← links)
- Determinants for Neoantigen Identification (Q91782530) (← links)